A Study on Drug Utilization Review and Potential Drug-Drug Interactions in Chronic Kidney Disease Patients

Ramakrishna Prudhivi; Monika K A; K S Charitha; M Ramana Reddy; K Vaishnavi; Jyothi

Authors

Ramakrishna Prudhivi
Monika K A
K S Charitha
M Ramana Reddy
K Vaishnavi
Jyothi

Keywords:

chronic kidney disease (CKD), drug-drug interactions (DDIs), drug utilization review (DUR)

Abstract

Abstract not found

Downloads

How to Cite

A Study on Drug Utilization Review and Potential Drug-Drug Interactions in Chronic Kidney Disease Patients. (2018). Global Journal of Medical Research, 18(B4), 1-9. https://medicalresearchjournal.org/index.php/GJMR/article/view/1582

Download Citation

References

C Donald, Rizzo (2010) Fundamentals of Anatomy & Physiology. 3, 428-430.

L Appel, Wright Greene, T Kusek, J, Lewis Wang, X Lipkowitz, M, Norris Bakris, G Rahman, M Contreras, G (2008) Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. 168(8), 832-839.

G Modi, V Jha (2006) The incidence of end-stage renal disease in India: A population-based study. 70(12), 2131-2133.

Vijay Kher (2002) End-stage renal disease in developing countries. 62(1), 350-362.

A Singh, Y Farag, B Mittal, K Subramanian, S Reddy, Acharya Almeida, A Channakeshavamurthy, A Ballal, H Gaccione, P Issacs, R (2013) Epidemiology and risk factors of chronic kidney disease in India-results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. (14), 114-125.

Roderick, Jeffrey Yuen, H, Godfrey West, J Wright, J (2015) Smaller kidney size at birth in South Asians: findings from the Born in Bradford birth cohort study. (31), 455-465.

R Thomas, A Kanso, J Sedor (2008) Chronic kidney disease and its complications. 35(2), 329-344.

Collins Foley, R Gilbertson, D Chen, S (2015) United States Renal Data System public health surveillance of chronic kidney disease and endstage renal disease. (5), 2-7.

Rakesh Patel (2003) Polypharmacy and the Elderly. 26(3), 166-169.

Nancy Mason (2011) Polypharmacy and medication-related complications in the chronic kidney disease patient. 20(5), 492-497.

Sarah Jones, Sunil Bhandari (1051) The prevalence of potentially inappropriate medication prescribing in elderly patients with chronic kidney disease. 89(1051), 247-250.

Owen Wade (1984) Plenary Lecture. 215(S683), 7-9.

I Edwards, Jeffrey Aronson (2000) Adverse drug reactions: definitions, diagnosis, and management. 356(9237), 1255-1259.

Munir Pirmohamed, Sally James, Shaun Meakin, Chris Green, Andrew Scott, Thomas Walley, Keith Farrar, B Park, Alasdair Breckenridge (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. 329(7456), 15-19.

M Rama, G Viswanathan, L Acharya, Attur Reddy, P Raghavan, S (2012) Assessment of drugdrug interactions among renal failure patients of nephrology ward in a South Indian tertiary care hospital. 74(1), 63-68.

J Kellum, N Lameire, P Aspelin, R Barsoum, Burdmann Goldstein, S Herzog, C Joannidis, M Kribben, A Levey, A Macleod, A (2012) Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. (2), 1-38.

P Rachana, H Anuradha (2014) Anti hypertensive prescribing patterns and cost analysis for primary hypertension: a retrospective study. (8), 19-22.

T Tamilselvan, A Veerapandiyan, N Karthik (2014) Prevalence and Drug Utilization Pattern in Hepatic Impairment Patients at a Tertiary Care Hospital. 6(7), 1878-1883.

N Anand, I Nayak, Advaitha Thaikattil, N Kantanavar, K Anand, S (1920) Antimicrobial agents' utilization and cost pattern in an Intensive Care Unit of a Teaching Hospital in South India. Indian journal of critical care medicine: peer-reviewed. (5), 274-279.

Fraser, Roderick, May Mcintyre, N Mcintyre, C Fluck, R Shardlow, A Taal, M (2015) The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. (16), 193.

Pranavi Dasari, K Venkateshwarlu, Rajkumar Venisetty (2014) A prospective observational study of probiotics in chronic kidney disease.. 12(02), 363-367.

Amit Ranjan, Akhil Kolli, Raghu Bapi Raju, K Rashidah, Ansari (2017) Management of Hypertension in CKD Patients Undergoing Maintenance Hemodialysis: A Prospective Cross-Sectional Study. (1), 1-8.

Devi George, J (2008) Diabetic nephropathy: Prescription trends in tertiary care. 70(3), 374-378.

Zbigniew Heleniak, Magdalena Cieplińska, Tomasz Szychliński, Dymitr Rychter, Kalina Jagodzińska, Alicja Kłos, Izabela Kuźmiuk, Marzena Tylicka, Leszek Tylicki, Bolesław Rutkowski, Alicja Dębska-Ślizień (2017) Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease. 30(6), 781-786.

Soumya Santra, Divya Agrawal, Sanjay Kumar, Sudhanshusekhar Mishra (2015) A Study on the Drug Utilization Pattern in Patients with Chronic Kidney Disease with Emphasis on Antibiotics. 2(3), 85.

A Joshi, D Holdford, D Brophy, S Harpe, D Mays, T Gehr (2012) Utilization patterns of IV iron and erythropoiesis stimulating agents in anemic chronic kidney disease patients: a multihospital study. 1-11.

S Chacko, J Shareef, J Kamath (2016) Assessment of Drug-Drug Interactions in Chronic Kidney Disease Patients in Nephrology Unit of A Tertiary Care Teaching Hospital. (6), 4962-4969.

A Chinwendu, Joda Oyetunde, O Udezi, W (2017) Evaluation of Drug-Drug Interactions Among Chronic Kidney Disease Patients of Nephrology Unit in the University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State. 8.